Abstract:Purpose: Rex shunt is an optimal surgery for the treatment of extra-hepatic portal venous obstruction (EHPVO) in children. Anticoagulant therapy has been used to keep the patency of the bypass vein in the Rex shunt. This study was to investigate the effectiveness of anticoagulant therapy using heparin combined with Plavix in improving the prognosis and shunt patency of Rex shunt. Methods: From January 2010 to September 2019, 51 children with EHPVO underwent a portal cavernoma- Rex shunt. Based on whether using the anticoagulant therapy after the Rex shunt, all patients were divided into two groups: the anticoagulant group and the non-anticoagulant group. The diameter and flow velocity of the bypass vein were measured by the post-operative ultrasound, which was used to calculate the flow volume of the bypass vein (FV) and standard portal venous flow (SPVF). The bypass venous flow index (BVFI) was used to evaluate the ability of portal blood into the liver through the bypass vein after the Rex shunt, which was a ratio of FV to SPVF. The incidence of post-operative re-bleeding, the postoperative patency rate of the bypass vein, the remission rate of postoperative hypersplenism, the remission rate of postoperative esophagogastric varices and the BVFI were compared between the two groups. Results: Of the 51 patients, 12 patients in the anticoagulant group were treated with heparin combined with Plavix after Rex shunt; 39 patients in the non-anticoagulant group were not treated with any anticoagulant therapy. 8 of 51 patients suffered from postoperative re-bleeding, of whom 6 patients with thrombosis of the bypass vein and 2 patients with anastomotic stenosis of the bypass vein. All 8 patients with re-bleeding belonged to the non-anticoagulant group. The remission rate of hypersplenism was no significant difference between the two groups after surgery (91% vs. 58%, P = 0.100). However, 3 patients without hypersplenism before surgery suffered from hypersplenism after surgery, who belonged to the non-anticoagulant group. There was no significant difference in the remission rate of esophagogastric varices (33% vs. 46%, P = 1.000). The BVFI of the anticoagulant group was significantly higher than that of the non-anticoagulant group (5.71 ± 5.89 vs. 1.1 ± 1.52, P = 0.003). Conclusions: Anticoagulant therapy using heparin combined with Plavix plays an important role in maintaining the patency of the bypass vein, which improved the portal blood flow into the liver through the bypass vein after the Rex shunt.

Wedged hepatic vein portovenography for assessment of Rex vein patency in children with extrahepatic portal venous obstruction

Medium-to Long-term Outcomes of Rex Shunt in 105 Children With Extrahepatic Portal Vein Obstruction in China

Percutaneous recanalization of non-cirrhotic extrahepatic portal vein obstruction in children: technical considerations in a preliminary cohort

Effectiveness of anticoagulant therapy using heparin combined with Plavix after Rex shunt

Location and extent of cavernous transformation of the portal vein dictates different visceral side revascularization in Meso-Rex bypass

Modified Meso-Rex Bypass with Umbilical Vein Recanalization and Intra-Operative Stenting

Case Report Of A Modified Meso-Rex Bypass As A Treatment Technique For Late-Onset Portal Vein Cavernous Transformation With Portal Hypertension After Adult Deceased-Donor Liver Transplantation

An Audit of Extrahepatic Portal Vein Obstruction: Experience from Tertiary Referral Center

Value of portal wedged venography in pediatric cavernous transformation of portal vein

Safety and effectiveness of renoportal bypass in patients with complete portal vein thrombosis: An analysis of 10 patients

Trans-splenic Access for Portal Venous Interventions in Children: Do Benefits Outweigh Risks?

Hepatic vein reconstruction during hepatectomy: A feasible and underused technique

A Rare Case of Extrahepatic Portal Venous Obstruction in a Nine-Year-Old Female and Its Management: A Case Report

Ten‐year follow‐up of cavoportal hemitransposition in pediatric liver transplantation for complete portomesenteric venous thrombosis: A case report and literature review

Transfemoral hepatic vein access in double vein embolization - initial experience and feasibility

Venous Congestion Assessed by Venous Excess Ultrasound (VExUS) and Acute Kidney Injury in Children with Right Ventricular Dysfunction

Hepatic venous pressure gradient after portal vein embolization: An accurate predictor of future liver remnant hypertrophy

Extrahepatic Portal Vein Thrombosis, an Important Cause of Portal Hypertension in Children

Preoperative assessment of the portal vein in pediatric liver transplantation recipients: comparison of ultrasonography and spiral CT portography

Ectopic Variceal Bleeding from the Hepaticojejunostomy due to Extrahepatic Portal Vein Occlusion: How to Treat?

Early detection and management of portal vein thrombosis after hepatic transplantation: A case report